Higher risk of psychotropic medication use after sexual harassment in the workplace

workplace harassment
Credit: CC0 Public Domain

Sexual and gender-based harassment in the workplace can contribute to the development of mental ill-health requiring treatment with antidepressants and anti-anxiety medication, a study from Karolinska Institutet in Sweden published in the journal Occupational and Environmental Medicine reports.

"We know from previous studies that there's a link between sexual and gender-based harassment at the workplace and mental ill-health," says the study's corresponding author Katrina Blindow, doctoral student at the Institute of Environmental Medicine, Karolinska Institutet. "Our study shows for the first time an increased risk for victims to be prescribed psychotropic medication, which suggests serious and lasting psychological problems."

In the study, an average of 5.2 and 7.5 percent of more than 23,000 participants said that they had been subjected to sexual or gender-based harassment, respectively, in their workplace under the past 12 months. Gender-based harassment involves non-sexualising, demeaning treatment and comments related to one's gender. The survey was conducted by the Swedish Work Environment Authority and distributed to a random selection of the working population in Sweden between 2005 and 2013. Information about participants' purchases of antidepressants and anxiolytics in up to nine years following their survey participation was added from the Prescribed Drug Register through the Swedish personal number.

The analyses showed that people who reported having been subjected to sexual or gender-based harassment had 20 percent higher risk of use than those who had not, a figure that rose to 31 percent for people who reported having been subjected to both sexual and gender-based harassment. There was no difference in these findings between women and men.

The study cannot determine any , and the researchers note that residual confounders beyond those factors considered in this study may be at play.

"The results suggest that sexual and gender-based harassment can have lasting consequences for victims," says Katrina Blindow. "Healthcare professionals need to be aware that such at work can be a cause of serious mental ill-health. Besides the treatment of their acute health problems, victims might also need support in changing an unsustainable work situation."

The study was conducted in collaboration with researchers from Karolinska Institutet, Uppsala University and Stockholm University, and financed by the Swedish Research Council for Health, Working Life and Welfare (Forte) and the Swedish Research Council.

Explore further

Connection between exposure and long-term sick leave

More information: Katrina Julia Blindow et al, Sexual and gender harassment and use of psychotropic medication among Swedish workers: a prospective cohort study, Occupational and Environmental Medicine (2022). DOI: 10.1136/oemed-2021-108087
Citation: Higher risk of psychotropic medication use after sexual harassment in the workplace (2022, March 10) retrieved 25 June 2022 from https://phys.org/news/2022-03-higher-psychotropic-medication-sexual-workplace.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors